Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

Degranulation deconstructed.

Baehner RL, Karnovsky MJ.

J Clin Invest. 2012 May;122(5):1596-7.

2.

A pathologist's odyssey.

Karnovsky MJ.

Annu Rev Pathol. 2006;1:1-22. No abstract available.

PMID:
18039106
3.

Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells.

Fan WH, Karnovsky MJ.

J Biol Chem. 2002 Mar 22;277(12):9800-5. Epub 2001 Dec 28.

4.

Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro.

Fan WH, Pech M, Karnovsky MJ.

Eur J Cell Biol. 2000 Dec;79(12):915-23.

PMID:
11152282
5.

Perivascular graft heparin delivery using biodegradable polymer wraps.

Edelman ER, Nathan A, Katada M, Gates J, Karnovsky MJ.

Biomaterials. 2000 Nov;21(22):2279-86.

PMID:
11026634
6.

Activation of protein kinase C inhibits the expression of connective tissue growth factor.

Fan WH, Karnovsky MJ.

Biochem Biophys Res Commun. 2000 Aug 28;275(2):312-21.

PMID:
10964664
7.

Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis.

Hirsch GM, Kearsey J, Burt T, Karnovsky MJ, Lee T.

Eur J Cardiothorac Surg. 1998 Jul;14(1):89-96; discussion 96-7.

PMID:
9726621
8.

Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells.

Steinbeck MJ, Kim JK, Trudeau MJ, Hauschka PV, Karnovsky MJ.

J Cell Physiol. 1998 Sep;176(3):574-87.

10.

Enhancement of diaminobenzidine colorimetric signal in immunoblotting.

Pukac LA, Carter JE, Morrison KS, Karnovsky MJ.

Biotechniques. 1997 Sep;23(3):385-8. No abstract available.

11.

Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.

Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ.

J Cell Physiol. 1997 Jul;172(1):69-78.

PMID:
9207927
12.

Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin.

Rogers C, Welt FG, Karnovsky MJ, Edelman ER.

Arterioscler Thromb Vasc Biol. 1996 Oct;16(10):1312-8.

PMID:
8857930
13.

Suppressors of oxygen metabolites fail to reduce vein graft intimal hyperplasia.

Gates JD, Hirsch GM, Karnovsky MJ.

Arch Surg. 1995 Sep;130(9):976-80.

PMID:
7661683
14.

Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.

Russell ME, Wallace AF, Wyner LR, Newell JB, Karnovsky MJ.

Circulation. 1995 Aug 1;92(3):457-64.

PMID:
7543380
15.

Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.

Shin YT, Adams DH, Wyner LR, Akalin E, Sayegh MH, Karnovsky MJ.

Transplantation. 1995 Jun 27;59(12):1647-53.

PMID:
7604433
16.
17.

Modulation of inflammatory activation pathways in the Lewis-to-F-344 rat chronic cardiac rejection model.

Russell ME, Hancock WW, Wallace AF, Wyner LR, Karnovsky MJ.

Transplant Proc. 1995 Jun;27(3):2100-4. No abstract available.

PMID:
7792898
18.

Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection.

Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibinga NE, Wyner LR, Karnovsky MJ.

Transplantation. 1995 Feb 27;59(4):572-8.

PMID:
7533347
19.
20.

NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone.

Steinbeck MJ, Appel WH Jr, Verhoeven AJ, Karnovsky MJ.

J Cell Biol. 1994 Aug;126(3):765-72.

21.

Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis.

Russell ME, Utans U, Wallace AF, Liang P, Arceci RJ, Karnovsky MJ, Wyner LR, Yamashita Y, Tarn C.

J Clin Invest. 1994 Aug;94(2):722-30.

22.

Robert Feulgen Lecture 1994. Cytochemistry and reactive oxygen species: a retrospective.

Karnovsky MJ.

Histochemistry. 1994 Aug;102(1):15-27. Review.

PMID:
7814266
23.

Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display.

Utans U, Liang P, Wyner LR, Karnovsky MJ, Russell ME.

Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6463-7.

24.

Mapping the heparin-binding sites on type I collagen monomers and fibrils.

San Antonio JD, Lander AD, Karnovsky MJ, Slayter HS.

J Cell Biol. 1994 Jun;125(5):1179-88.

25.

Chronic rejection in experimental cardiac transplantation in a rat model.

Karnovsky MJ, Russell ME, Hancock W, Sayegh MH, Adams DH.

Clin Transplant. 1994 Jun;8(3 Pt 2):308-12.

PMID:
8061372
26.

Interactions of syndecan-1 and heparin with human collagens.

San Antonio JD, Karnovsky MJ, Gay S, Sanderson RD, Lander AD.

Glycobiology. 1994 Jun;4(3):327-32.

27.
29.

The DAB-Mn++ cytochemical method revisited: validation of specificity for superoxide.

Steinbeck MJ, Khan AU, Appel WH Jr, Karnovsky MJ.

J Histochem Cytochem. 1993 Nov;41(11):1659-67. Erratum in: J Histochem Cytochem 1994 Jan;42(1):127.

PMID:
8292156
30.

Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development.

Adams DH, Wyner LR, Karnovsky MJ.

Transplantation. 1993 Oct;56(4):794-9.

PMID:
8212197
31.

Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells.

Ottlinger ME, Pukac LA, Karnovsky MJ.

J Biol Chem. 1993 Sep 15;268(26):19173-6.

32.
33.

Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model.

Adams DH, Russell ME, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ.

Immunol Rev. 1993 Aug;134:5-19. Review.

PMID:
8225375
35.

Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts.

Russell ME, Adams DH, Wyner LR, Yamashita Y, Halnon NJ, Karnovsky MJ.

Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6086-90.

36.

Alpha 1-VIII collagen is expressed in the rat glomerulus and in resident glomerular cells.

Rosenblum ND, Briscoe DM, Karnovsky MJ, Olsen BR.

Am J Physiol. 1993 Jun;264(6 Pt 2):F1003-10.

PMID:
8322888
37.

Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.

San Antonio JD, Slover J, Lawler J, Karnovsky MJ, Lander AD.

Biochemistry. 1993 May 11;32(18):4746-55.

PMID:
8490019
38.

Protamine and protamine-insulins exacerbate the vascular response to injury.

Edelman ER, Pukac LA, Karnovsky MJ.

J Clin Invest. 1993 May;91(5):2308-13.

39.

Isolation of heparin-insensitive aortic smooth muscle cells. Growth and differentiation.

San Antonio JD, Karnovsky MJ, Ottlinger ME, Schillig R, Pukac LA.

Arterioscler Thromb. 1993 May;13(5):748-57.

PMID:
8485126
40.

Inhibition of graft arteriosclerosis by modulation of the inflammatory response.

Adams DH, Wyner LR, Steinbeck MJ, Karnovsky MJ.

Transplant Proc. 1993 Apr;25(2):2092-4. No abstract available.

PMID:
8470282
41.

Cardiac graft arteriosclerosis in the rat.

Adams DH, Wyner LR, Karnovsky MJ.

Transplant Proc. 1993 Apr;25(2):2071-3. No abstract available.

PMID:
8470275
42.

Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition.

Edelman ER, Nugent MA, Karnovsky MJ.

Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1513-7.

43.
44.

Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.

Adams DH, Tilney NL, Collins JJ Jr, Karnovsky MJ.

Transplantation. 1992 May;53(5):1115-9.

PMID:
1585476
45.
46.
47.

Heparin inhibits the attachment and growth of Balb/c-3T3 fibroblasts on collagen substrata.

San Antonio JD, Lander AD, Wright TC, Karnovsky MJ.

J Cell Physiol. 1992 Jan;150(1):8-16.

48.

A putative role of hypercholesterolemia in progressive glomerular injury.

Diamond JR, Karnovsky MJ.

Annu Rev Med. 1992;43:83-92. Review.

PMID:
1580608
49.

Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.

Pukac LA, Hirsch GM, Lormeau JC, Petitou M, Choay J, Karnovsky MJ.

Am J Pathol. 1991 Dec;139(6):1501-9.

Supplemental Content

Loading ...
Support Center